Skip to main content
Premium Trial:

Request an Annual Quote

Euformatics Signs Distribution Deal With Saudi Arabia's Al-Jeel

NEW YORK – Euformatics said Monday that it has entered into a distribution partnership for Saudi Arabia with Al-Jeel Medical and Trading Co.

Riyadh, Saudi Arabia-based Al-Jeel will offer the entire Euformatics Omnomics suite of interpretation and validation software for next-generation sequencing to its home market. These products include OmnomicsNGS, a CE-marked variant interpretation and reporting package, the OmnomicsQ quality control tool, and the OmnomicsV validation tool.

Al-Jeel also recently became the Saudi distributor for Illumina sequencing instrumentation and kits, and Euformatics' software is meant to complement Illumina-enabled NGS Illumina.

"As the NGS market grows in Saudi Arabia and more laboratories see the value of NGS techniques, we are confident that OmnomicsQ will ensure that the quality of the generated data is high, while OmnomicsNGS will help our medical professionals to quickly annotate and report on dangerous variants," said Abdul Ghani Marwan Elajou, general manager of Al-Jeel, in a statement.

This deal continues Euformatics' strategy of expansion through local and regional distribution partners, though the Espoo, Finland-based firm already has customers in Saudi Arabia, including King Fahad Specialist Hospital in Dammam.

The company did move into the Middle East region in late 2019 by virtue of a distribution agreement with Alliance Global.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.